SFL Pharma has a full Quality Management System and holds an Establishment License with Swissmedic. As Marketing Authorization Holder for medicinal products in Switzerland, we also manage the following activities:
- Quality assurance
- Lifecycle management of the medicinal product
Shayesteh Fürst-Ladani is the CEO and founder of SFL Pharma. Mrs. Fürst-Ladani has many years of experience in major pharma and biotech, as well as premium consulting companies. She is President of the Rare Disease Action Forum (RDAF), a Swiss Think Tank for improving access to medicines for patients with orphan diseases in Switzerland. She received her MSc in Microbiology from the University of Vienna, Austria and an MBA from the Open University Business School, Milton Keynes, UK.